CA2478901A1 - Methods of virus production - Google Patents

Methods of virus production Download PDF

Info

Publication number
CA2478901A1
CA2478901A1 CA002478901A CA2478901A CA2478901A1 CA 2478901 A1 CA2478901 A1 CA 2478901A1 CA 002478901 A CA002478901 A CA 002478901A CA 2478901 A CA2478901 A CA 2478901A CA 2478901 A1 CA2478901 A1 CA 2478901A1
Authority
CA
Canada
Prior art keywords
virus
temperature
culture
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002478901A
Other languages
English (en)
French (fr)
Inventor
Liangzhi Xie
Charles F. Goochee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2478901A1 publication Critical patent/CA2478901A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002478901A 2002-03-29 2003-03-27 Methods of virus production Abandoned CA2478901A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36865402P 2002-03-29 2002-03-29
US60/368,654 2002-03-29
PCT/US2003/009269 WO2003085138A1 (en) 2002-03-29 2003-03-27 Methods of virus production

Publications (1)

Publication Number Publication Date
CA2478901A1 true CA2478901A1 (en) 2003-10-16

Family

ID=28791896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002478901A Abandoned CA2478901A1 (en) 2002-03-29 2003-03-27 Methods of virus production

Country Status (9)

Country Link
US (1) US7344873B2 (cg-RX-API-DMAC7.html)
EP (1) EP1492891B1 (cg-RX-API-DMAC7.html)
JP (1) JP4413012B2 (cg-RX-API-DMAC7.html)
AT (1) ATE386824T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003226012B2 (cg-RX-API-DMAC7.html)
CA (1) CA2478901A1 (cg-RX-API-DMAC7.html)
DE (1) DE60319210T2 (cg-RX-API-DMAC7.html)
ES (1) ES2299715T3 (cg-RX-API-DMAC7.html)
WO (1) WO2003085138A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155863B1 (en) * 2007-05-04 2014-08-13 Baxter International Inc. Two-step temperature profile for the propagation of viruses
SG184833A1 (en) 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
EP2686423A4 (en) 2011-03-14 2015-01-28 Nat Res Council Canada Method of viral production in cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US5618714A (en) 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
DE69633565T3 (de) * 1995-06-15 2013-01-17 Crucell Holland B.V. Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
JP2003530307A (ja) 1999-07-06 2003-10-14 メルク・アンド・カンパニー・インコーポレーテッド gag遺伝子保有アデノウイルスHIVワクチン
JP2004508064A (ja) 2000-09-15 2004-03-18 メルク エンド カムパニー インコーポレーテッド コドン最適化hiv1−gag、pol、nefおよび修飾体を発現する増強された第1世代アデノウイルスワクチン

Also Published As

Publication number Publication date
JP2005521423A (ja) 2005-07-21
EP1492891B1 (en) 2008-02-20
JP4413012B2 (ja) 2010-02-10
WO2003085138A1 (en) 2003-10-16
DE60319210D1 (de) 2008-04-03
US7344873B2 (en) 2008-03-18
EP1492891A1 (en) 2005-01-05
US20050176146A1 (en) 2005-08-11
ES2299715T3 (es) 2008-06-01
EP1492891A4 (en) 2005-08-24
DE60319210T2 (de) 2009-02-12
ATE386824T1 (de) 2008-03-15
AU2003226012B2 (en) 2007-05-24
AU2003226012A1 (en) 2003-10-20

Similar Documents

Publication Publication Date Title
Nadeau et al. Production of adenovirus vector for gene therapy
CN102203242B (zh) 产生腺病毒载体的方法
JP5250155B2 (ja) Ad26アデノウイルスベクターの製造方法
KR102044051B1 (ko) 터미널 말단이 변경된 재조합 아데노바이러스의 배치
JP2013165736A (ja) ウイルス産生プロセス
US20180080010A1 (en) Method for the production of ad26 adenoviral vectors
Shen et al. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1. 3)
JP2015535687A (ja) 新規mvaウイルス及びその使用
WO2021139147A1 (zh) 一种腺病毒二价疫苗
EP1492891B1 (en) Methods of virus production
CN107523555A (zh) 获得病毒的方法
TW202237831A (zh) 生產腺病毒之方法
Trabelsi et al. Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1. CR. pIX
Fernandes et al. Upstream bioprocess for adenovirus vectors
US20240033345A1 (en) Method for producing virus
Subramanian et al. Scaleable production of adenoviral vectors by transfection of adherent PER. C6 cells
Zecchini et al. Production of high titre disabled infectious single cycle (DISC) HSV from a microcarrier culture
CN1231598C (zh) 一种重组禽腺病毒的制备方法
Kirilin et al. Adenovirus Serotype 26 Cultivation on a Production Scale: Optimization of Conditions
CN120738288A (zh) 重组腺病毒载体和基于该载体的复制型腺病毒重组体及其构建方法
JPH0622758A (ja) 新規な新症候出血熱ワクチンおよびその製造方法
Wissing et al. CAP® AD–A VERSATILE PLATFORM FOR RCA-FREE, INDUSTRIAL SCALE ADENOVIRAL VECTOR PRODUCTION
WO2009006300A2 (en) Production cell lines for adenoviral manufacturing

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued